NCCM
WST icon

Nine Chapters Capital Management’s West Pharmaceutical WST Stock Holding History

Nine Chapters Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,700
Closed -$283K – 1190
2014
Q2 		$283K Buy
+6,700
New +$287K 0.02% 738
2014
Q1 		– Sell
-4,600
Closed -$226K – 969
2013
Q4 		$226K Sell
4,600
-5,000
-52% -$234K 0.02% 688
2013
Q3 		$395K Buy
+9,600
New +$366K 0.05% 476

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Nine Chapters Capital Management's WST Position: Q3 2014 in Review

Nine Chapters Capital Management sold out of West Pharmaceutical (WST) in Q3 2014, closing a stake of 6,700 shares — an estimated $283K sold.

Nine Chapters Capital Management first reported a position in WST in Q3 2013 and held it in 3 quarters. The position peaked at $395K in Q3 2013. 213 funds tracked by Wall St. Rank hold WST as of Q3 2014.

  • Nine Chapters Capital Management reported no remaining West Pharmaceutical position as of Q3 2014 after selling out during the quarter.
  • Nine Chapters Capital Management sold 6,700 West Pharmaceutical shares in Q3 2014, an estimated $283K.
  • Nine Chapters Capital Management first reported a position in West Pharmaceutical in Q3 2013 and held it in 3 quarters.
  • Nine Chapters Capital Management's West Pharmaceutical position peaked at $395K in Q3 2013.
  • 213 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2014.

Based on Nine Chapters Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.